Quantitative vibration perception threshold in assessing diabetic polyneuropathy: Should the cut-off value be adjusted for Chinese individuals with type 2 diabetes?

被引:16
作者
Liu, Min [1 ]
Gao, Yun [1 ]
Chen, Da-Wei [1 ]
Lin, Shuang [1 ]
Wang, Chun [1 ]
Chen, Li-Hong [1 ]
Ran, Xing-Wu [1 ]
机构
[1] Sichuan Univ, West China Hosp, Diabet Foot Care Ctr, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Diabetic polyneuropathy; Type  2 diabetes mellitus; Vibration perception threshold;
D O I
10.1111/jdi.13515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/Introduction To examine the performance and identify the optimal threshold of vibration perception threshold (VPT) for diagnosing diabetic polyneuropathy (DPN) in a Chinese population according to multiple definitions of DPN as gold standards. Materials and Methods VPT was determined in 421 Chinese individuals with type 2 diabetes, who simultaneously completed a questionnaire of neuropathic symptoms, and underwent the assessment of signs of peripheral neuropathy and electromyography tests. Three definitions of DPN (i.e., clinician-diagnosed DPN, abnormal nerve conduction and confirmed DPN) were taken as reference gold standards. Results Vibration perception threshold was a specific measure for all three groups of DPN outcomes, with the highest specificity noted for clinician-diagnosed DPN (85.1%). The specificity for abnormal nerve conduction and confirmed DPN was 77.0 and 76.6%, respectively. The sensitivity of VPT was 67.0% for clinician-diagnosed DPN, 66.5% for abnormal nerve conduction and 67.2% for confirmed DPN. The optimal cut-off threshold for abnormal nerve conduction, as well as confirmed DPN, was VPT >14.9 V. The specificity and sensitivity of VPT >14.9 V as the cut-off value for clinician-diagnosed DPN were 85.6 and 66.2%, respectively. When taking clinician-diagnosed DPN as the gold standard, the performance of VPT for diagnosing DPN was best with an area under the curve value of 0.804. Conclusions VPT measured using the neurothesiometer had relatively high specificity and best performance for diagnosing DPN when clinician-diagnosed DPN rather than abnormal nerve conduction was taken as the gold standard in a Chinese population. A VPT value of >= 15 V might be equally applicable for diagnosing DPN in a Chinese population.
引用
收藏
页码:1663 / 1670
页数:8
相关论文
共 44 条
  • [1] Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration
    Abbott, CA
    Vileikyte, L
    Williamson, S
    Carrington, AL
    Boulton, AJM
    [J]. DIABETES CARE, 1998, 21 (07) : 1071 - 1075
  • [2] The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study
    Adams, O. P.
    Herbert, J. R.
    Howitt, C.
    Unwin, N.
    [J]. DIABETIC MEDICINE, 2019, 36 (12) : 1629 - 1636
  • [3] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [4] 2-S
  • [5] Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018
    不详
    [J]. DIABETES CARE, 2018, 41 : S105 - S118
  • [6] Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration
    Armstrong, DG
    Lavery, LA
    Vela, SA
    Quebedeaux, TL
    Fleischli, JG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (03) : 289 - 292
  • [7] Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level
    Azzopardi, Kurt
    Gatt, Alfred
    Chockalingam, Nachiappan
    Formosa, Cynthia
    [J]. PRIMARY CARE DIABETES, 2018, 12 (02) : 111 - 115
  • [8] Correlation between markers of peripheral nerve function and structure in type 1 diabetes
    Borire, Adeniyi A.
    Issar, Tushar
    Kwai, Natalie C.
    Visser, Leo H.
    Simon, Neil G.
    Poynten, Ann M.
    Kiernan, Matthew C.
    Krishnan, Arun V.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (07)
  • [9] Diabetic neuropathies - A statement by the American Diabetes Association
    Boulton, AJM
    Vinik, AI
    Arezzo, JC
    Bril, V
    Feldman, EL
    Freeman, R
    Malik, RA
    Maser, RE
    Sosenko, JM
    Ziegler, D
    [J]. DIABETES CARE, 2005, 28 (04) : 956 - 962
  • [10] Neuropathic diabetic foot ulcers
    Boulton, AJM
    Kirsner, RS
    Vileikyte, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) : 48 - 55